Tag: global heart transplant market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Heart Transplant Market?

In the past few years, the heart transplant market has seen significant growth. The estimated increase is from $11.49 billion in 2024 to $12.62 billion in 2025, which represents a compound annual growth rate (CAGR) of 9.9%. The factors contributing to the growth during the historic period include medical progress, heightened awareness and education, developments in organ preservation, and improvements in healthcare infrastructure.

The market size for heart transplants is forecasted to experience a robust increase in the forthcoming years. It is set to escalate to $18.14 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. This anticipated upturn during the forecast period can be credited to government backing and funds, the worldwide expansion of transplant programs, growing capacity of transplant centers, and the incorporation of telemedicine and remote monitoring. Noteworthy trends anticipated during this forecast period involve technological progression, artificial heart and augmentative devices, and the use of artificial intelligence (AI) for donor organ selection.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

What Drivers Are Accelerating Expansion Of The Heart Transplant Market?

The heart transplant market is predicted to grow due to the increasing instances of cardiovascular diseases. These diseases encompass a variety of conditions directly impacting the heart and blood arteries. For those individuals suffering from severe heart failure who have seen no improvement from other treatments, a heart transplant serves as the final option. This process enhances the quality of life and prolongs longevity. For example, data from the British Heart Foundation, a cardiovascular research charity based in the UK, point out that around 7.6 million men and women in the UK suffer from heart and circulatory diseases, with 4 million men and 3.6 million women affected. Projections suggest an additional 1 million could be suffering by 2030, and an increase of 2 million by 2040 than the current status. Consequently, the rising prevalence of cardiovascular diseases is set to influence the growth of the heart transplant market.

What Are The Key Segment Trends Observed In The Heart Transplant Market?

The heart transplantmarket covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types

2) By Transplant: Autograft; Allograft; Other Transplants

3) By End-User: Hospitals; Cardiac Institutes; Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant

Which Disruptive Trends Are Driving Change Across The Heart Transplant Market?

Leading firms in the heart transplant market are progressively concentrating on introducing novel solutions like heart preservation technology to enhance patient results and the rate of successful transplants. This technology significantly prolongs the heart’s lifespan outside the body when compared with the conventional ice storage technique, leading to better results and fewer post-transplant issues. For instance, in May 2023, Xvivo Perfusion AB, a medical technology corporation based in Sweden, obtained approval from the US FDA for its heart preservation technology’s IDE application, enabling the corporation to instigate the ‘PRESERVE Clinical Trial.’ This study is a forward-looking, multicenter, single-arm, open-label investigation centered on the assessment of hearts transplanted following non-ischemic heart conservation from extended donors, most notably DCD hearts. XVIVO’s heart preservation technology’s key unique characteristic is its non-ischemic hypothermic perfusion system, utilizing cold, oxygenated perfusion for preserving donor hearts during transport.

Who Are The Major Stakeholders Operating In The Heart Transplant Market?

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What Regional Factors Are Accelerating Growth In The Heart Transplant Market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

Browse Through More Reports Similar to the Global Heart Transplant Market 2025, By The Business Research Company

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Heart Transplant Market Expected To Expand Between 2025 And 2029?

The heart transplant market has experienced significant expansion recently. It is projected to increase from $11.49 billion in 2024 to $12.62 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.9%. Historically, this growth can be attributed to advancements in medicine, greater awareness and education, progress in organ preservation techniques, and improvements in healthcare infrastructure.

The heart transplant market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $18.14 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. Key drivers for this growth include governmental aid and financial backing, the global expansion of transplant initiatives, enhanced capacity at transplant centers, and the incorporation of telemedicine alongside remote monitoring solutions. Significant trends emerging within this period encompass ongoing technological progress, the development of artificial hearts and assistive devices, and the application of artificial intelligence (AI) to optimize donor organ selection.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Which Factors And Drivers Are Influencing The Heart Transplant Market In 2025?

The increasing occurrence of cardiovascular conditions is projected to drive the expansion of the heart transplant market in the future. These diseases encompass various ailments impacting the heart and its associated blood vessels. A heart transplant serves as a final therapeutic option for patients experiencing end-stage heart failure, particularly when alternative treatments have proven ineffective. This procedure enhances the quality of life and prolongs the lifespan of recipients. For example, data from September 2024, provided by the British Heart Foundation, a UK-based cardiovascular research charity, indicates that around 7.6 million people in the UK are currently living with heart and circulatory diseases, consisting of 4 million men and 3.6 million women. Projections suggest this figure could grow by 1 million by 2030, potentially reaching an additional 2 million above current levels by 2040. Consequently, the widespread presence of cardiovascular diseases is set to be a key driver for the heart transplant market.

What Are The Major Segments Identified In The Heart Transplant Market?

The heart transplantmarket covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types

2) By Transplant: Autograft; Allograft; Other Transplants

3) By End-User: Hospitals; Cardiac Institutes; Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant

Which Ongoing Trends Are Expected To Shape The Heart Transplant Market Outlook?

Key players in the heart transplant market are increasingly focusing on developing innovative solutions, such as heart preservation technology, to enhance patient outcomes and improve transplant success rates. This technology significantly extends the preservation time of the heart outside the body compared to traditional ice storage, leading to improved outcomes and reduced post-transplantation complications. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) application for its heart preservation technology, enabling the company to initiate the ‘PRESERVE Clinical Trial.’ This trial is a prospective, multicenter, single-arm, open-label study aimed at evaluating hearts transplanted after non-ischemic heart preservation from extended donors, specifically including Donation after Circulatory Death (DCD) hearts. The main unique feature of XVIVO’s heart preservation technology is its non-ischemic hypothermic perfusion system, which utilizes cold, oxygenated perfusion to preserve donor hearts during transport.

Which Leading Companies Dominate The Heart Transplant Market Share?

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What Are The Key Regional Factors Influencing The Heart Transplant Market Growth?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Heart Transplant Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

Browse Through More Reports Similar to the Global Heart Transplant Market 2025, By The Business Research Company

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Heart Transplant Market Through 2034?

The market size for heart transplants has seen significant growth in the past few years. The size is estimated to expand from $11.49 billion in 2024 to $12.62 billion in 2025, witnessing a compound annual growth rate (CAGR) of 9.9%. Factors contributing to growth during the historic period include advancements in medical technology, enhanced awareness and education, developments in organ preservation methods, and improvements in healthcare infrastructure.

The market for heart transplants is predicted to experience significant expansion in the near future. The estimated market size is due to reach $18.14 billion in 2029 with a compound annual growth rate of 9.5%. The anticipated surge over the forecast period is largely due to factors such as government backing and funding, global expansion of transplant programs, augmentation of transplant center capacity, and inclusion of telemedicine and remote monitoring. Technological progress, artificial heart and aid devices, and the use of artificial intelligence in donor organ selection will be the major trends within the forecast period.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Heart Transplant Market?

The increasing presence of heart conditions is anticipated to stimulate growth in the heart transplantation market. These cardiovascular diseases encompass various conditions impacting the heart and blood vessels. A heart transplant procedure is oftentimes the final treatment option for patients with advanced heart failure who have seen no improvement with other treatments. Such a procedure can enhance quality of life and prolong life expectancy. For instance, per the British Heart Foundation, a charity based in the UK that focuses on cardiovascular research, approximately 7.6 million people in the UK, consisting of 4 million men and 3.6 million women, are presently dealing with heart and circulatory diseases. Projections indicate that this number could ascend by 1 million by 2030, and potentially see an increase of an additional 2 million by 2040 compared to the current figures. As such, the widespread nature of cardiovascular diseases is expected to fuel the heart transplant market.

Which Key Market Segments Comprise the Heart Transplant Market and Drive Its Revenue Growth?

The heart transplantmarket covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types

2) By Transplant: Autograft; Allograft; Other Transplants

3) By End-User: Hospitals; Cardiac Institutes; Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

Which Areas Are Leading Regions in the Heart Transplant Market Expansion Across the Globe?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theHeart Transplant Market Direction?

Key players in the heart transplant market, including companies like Xvivo Perfusion AB, are increasingly turning their attention towards fostering innovative solutions such as heart preservation technology. This technology aims to extend the preservation life of a heart outside the body compared to traditional ice storage methods. As a result, it promotes improved post-transplant conditions and fewer complications. In May 2023, Xvivo Perfusion, a medical technology firm based in Sweden, obtained the green light from the U.S. Food and Drug Administration for an Investigational Device Exemption (IDE) for its unique heart preservation technology. This approval ultimately kick-started the ‘PRESERVE Clinical Trial.’ The trial is a single-arm, open-label, prospective study angled towards assessing hearts transplanted from extended donors after employing non-ischemic heart preservation methods. This method includes Donation after Circulatory Death (DCD) hearts. One distinctive aspect of XVIVO’s heart preservation approach is its hypothermic perfusion system that is non-ischemic, using cold, oxygenated perfusion to preserve donor hearts during transit.

View the full report here:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

How Is the Heart Transplant Market Conceptually Defined?

A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the heart transplant industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Heart Transplant Market Expected to Grow Between 2025 And 2029?

The size of the heart transplant market has increased rapidly over the past few years. The market, which was valued at $11.49 billion in 2024, is expected to reach $12.66 billion by 2025, growing at an annual compound rate (CAGR) of 10.2%. The strong growth in the historic period is due to significant improvements in medical technology, greater awareness and education, progress in organ preservation, and advancements in healthcare infrastructure.

Projected to experience substantial growth in the coming years, the heart transplant market is set to reach a worth of $18.1 billion in 2029, a development marked by a compound annual growth rate of 9.3%. Factors contributing to this expected growth within the stipulated period include governmental backing and funding, worldwide expansion of transplant programs, augmentation of transplant center capabilities, and the integration of telemedicine and remote monitoring. Main trends expected within the forecast period encompass technological advancements, artificial heart and assist devices, as well as the use of artificial intelligence in donor organ selection.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Which Factors and External Forces Are Driving Demand in the Heart Transplant Market?

The rise in cardiovascular disease occurrences is projected to stimulate further expansion of the heart transplant market. Cardiovascular conditions, which mainly concern the heart and blood arteries, often necessitate a heart transplant at their extreme stages. This medical procedure, often a last resort for those with end-stage heart failure non-responsive to other treatments, enhances the quality of life and life expectancy. The British Heart Foundation, a respected cardiovascular research charity based in the UK, reported for September 2024 that about 7.6 million individuals, comprising 4 million men and 3.6 million women, are currently plagued with heart and circulatory diseases in the UK. They project this number to increase by one million by 2030 and by another two million by 2040, emphasizing the deepening grip of cardiovascular diseases. This cardiovascular disease prevalence thus primes the heart transplant market for growth. Emerging awareness concerning organ donation and transplantation is likely to further spur the heart transplant market’s expansion. This awareness encapsulates the level to which individuals and communities comprehend the processes, significance, and repercussions of organ donation and transplantation in healthcare. By increasing the understanding of organ donation and transplantation, the supply of donors can be expanded, wait-times for recipients reduced, and patient outcomes can be improved. The United Network for Organ Sharing, a US-based non-profit scientific and educational organization, reported in January 2023 a new annual record of 42,887 organ transplants performed in the US during 2022, marking a 3.7% increase from 2021. Notably, this includes having 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants performed, reflecting the heightened awareness about organ donation. Consequently, this burgeoning awareness about organ donation and transplantation stands to power the heart transplant market.

Which Segments in the Heart Transplant Offer the Most Growth?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

What Are the Fastest-Growing Geographies in the Heart Transplant Market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theHeart Transplant Market’s Growth?

Leading businesses present in the heart transplant market are more and more focusing on the development of novel solutions, like heart preservation technology, to enhance patient health outcomes and transplantation success rates. This technology significantly increases the time a heart can be preserved outside the body in comparison to the traditional ice storage method. Consequently, it allows for better patient health results and fewer post-surgery complications. For example, in May 2023, the U.S. Food and Drug Administration (FDA) gave Xvivo Perfusion AB, a medical technology enterprise based in Sweden, the approval for its Investigational Device Exemption (IDE) application regarding its heart preservation technology, enabling the company to kickstart the “PRESERVE Clinical Trial.” This is a prospective, open-label study conducted in multiple centers and single-handedly focuses on heart transplants performed post non-ischemic heart preservation from extended donors, especially including Donation after Circulatory Death (DCD) hearts. XVIVO’s heart preservation technology’s standout feature is its non-ischemic hypothermic perfusion system that employs cold, oxygenated perfusion to maintain donor hearts while being transported.

View the full report here:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What Are the Key Elements That Define the Heart Transplant Market?

A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theHeart Transplant Market?

The rise in cardiovascular diseases is anticipated to catalyze the expansion of the heart transplant market. These diseases encompass a variety of disorders impacting the heart and blood vessels. A heart transplant serves as the final treatment option for patients experiencing terminal heart failure who have not benefited from other therapies. It enhances life quality and extends life span. For instance, the British Heart Foundation reported in September 2024 that around 7.6 million people in the UK currently suffer from heart and circulatory diseases, with 4 million being men and 3.6 million being women. By 2030, this figure could escalate by 1 million, and by 2040, it is predicted to exceed the current statistics by 2 million. Thus, the high occurrence of cardiovascular diseases is set to stimulate the heart transplant market. A burgeoning awareness about organ donation and transplantation promises to accelerate the growth of the heart transplant market. This notion of understanding signifies the degree of knowledge and cognizance among individuals and societies regarding the procedures and importance of the subject matter in healthcare. A rise in this awareness greatly impacts the number of heart transplants, as it increases the donor pool, reduces recipient waiting time, and ameliorates patient results. For instance, The United Network for Organ Sharing, a US-based non-profit scientific and educational organization, disclosed a record 42,887 organ transplants were performed in the US, registering a 3.7% increment from 2021. In addition, awareness has led to a total of 9,528 liver transplants, 4,111 heart transplants and 2,692 lung transplants. Therefore, escalating awareness about organ donation and transplantation appears to be a primary driver for the heart transplant market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

How Has the Heart Transplant Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

Recent years have seen a swift expansion in the size of the heart transplant market. In terms of figures, it is predicted to rise from $11.49 billion in 2024 to $12.66 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this surge during the historic period include progress in medical technology, amplified awareness and education, developments in organ preservation methods, as well as improved healthcare infrastructure.

The market size for heart transplants is slated for robust growth over the next few years, expanding to a whopping $18.1 billion in 2029, which represents a compound annual growth rate (CAGR) of 9.3%. This growth during the prediction period can be traced back to factors such as government backing and funding, the global spread of transplant programs, the rise in the capacity of transplant centers, and the incorporation of telemedicine and remote surveillance. Key trends over this forecasted timeframe include the progression of technology, the advent of artificial hearts and support devices, as well as the role of artificial intelligence (AI) in selecting donor organs.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

Which Cutting-Edge Market Trends Are Expected to Drive theHeart Transplant Market’s Growth?

Leading corporations in the heart transplant market are intensifying their efforts on the creation of innovative solutions including heart preservation technology, aimed at enhancing patient recovery and success rates of transplantations. This technology extends preservation duration of the heart outside the body relative to conventional ice storage methods, thereby contributing to improved conditions and fewer post-transplant complications. For example, in May 2023, a clearance from the U.S. Food and Drug Administration (FDA) was achieved by Xvivo Perfusion AB, a medical technology firm from Sweden, for its heart preservation technology under the Investigational Device Exemption (IDE) application. Consequently, the company was granted permission to kickstart the “PRESERVE Clinical Trial”. This study is an open-label, single-arm, multicenter, and indicative trial, examining hearts transplanted following non-ischemic heart preservation from extended donors, specifically integrating Donation after Circulatory Death (DCD) hearts. The standout feature of XVIVO’s heart preservation technology is its non-ischemic hypothermic perfusion system which leverages cold, oxygenated perfusion to maintain donor hearts during transportation.

What Are the Leading Market Players Impacting theHeart Transplant Market’s Growth Trend?

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

How Are the Key Segments of the Heart Transplant Market Driving Opportunities and Innovations?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theHeart Transplant Market?# Market Expansion?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Heart Transplant Market 2025, By The Business Research Company:

Cardiac Arrhythmia Monitoring Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Marker Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Heart Transplant market size evolved in recent years?

The size of the heart transplant market has seen significant acceleration in growth in the last few years. The market, which was worth $11.49 billion in 2024, is projected to increase to $12.66 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.2%. The expansion during the historical period is credited to factors like advancements in medical technology, enhanced knowledge and education, progress in organ preservation techniques, and the development of the healthcare infrastructure.

What are the predictions for the heart transplant market size in the coming years?

The market for heart transplants is anticipated to experience robust expansion in the coming years, forecasted to reach $18.1 billion by 2029 with a 9.3% compound annual growth rate (CAGR). This projected surge during the period is likely to be driven by factors such as government backing and finance, the internationalization of transplant schemes, the growth of the capacity of transplant centres, and the employment of telemedicine and distant observation methods. Key trends for this period are expected to include technological progress, artificial hearts and aid tools, along with the utilization of artificial intelligence (AI) in selecting donor organs.

Get your heart transplant market report here!

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What key factors are fueling the growth of the heart transplant market?

The expected surge in cardiovascular diseases is anticipated to boost the heart transplant market’s growth over time. Cardiovascular diseases refer to various conditions impacting the heart and blood arteries. A heart transplant is the final treatment option for end-stage heart failure patients who haven’t found success with other treatments. Significantly, it improves the quality of life and extends longevity. For instance, as reported by the British Heart Foundation in September 2024, about 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. Predictions suggest that this number could rise by one million by 2030 and two million by 2040, over and above the present numbers. Consequently, the increasing instances of cardiovascular diseases will fuel the heart transplant market. The heart transplant market is forecasted to advance due to an increase in awareness about organ donation and transplantation. Such awareness pertains to the individual’s and communities’ comprehension, consciousness, and familiarity regarding organ donation and transplant processes’ importance and effects on healthcare. The rise in awareness about organ donation and transplantation notably affects the heart transplant sector by increasing the number of donors, reducing waiting times for recipients, and improving patient outcomes. For example, the United Network for Organ Sharing, a US-based non-profit educational and scientific institution, reported that a new yearly record of 42,887 organ transplants was set in the US in 2022, up 3.7% from 2021. In addition, due to increased awareness, liver transplants saw 9,528 procedures, heart transplants accounted for 4,111 surgeries, and lung transplants conducted 2,692 operations. Hence, the heart transplant market will be spurred by the growing awareness about organ donation and transplantation.

How is the global heart transplant market divided into key segments?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Who are the key firms paving the way for growth in the heart transplant market?

Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

Which trends are expected to transform the heart transplant market?

Leading corporations in the heart transplant market are concentrating their efforts on creating innovative solutions, such as heart preservation technology, to enhance patient results and the success rate of transplants. This advancement significantly lengthens the lifespan of the heart outside the body when compared to conventional ice storage, leading to improved results and fewer post-transplant issues. For example, XVIVO Perfusion AB, a medical technology firm located in Sweden, secured approval from the U.S. Food and Drug Administration (FDA) for a Investigational Device Exemption (IDE) application for its heart preservation technology in May 2023. This approval paved the way for the launch of the “PRESERVE Clinical Trial,” a prospective, multicenter, single-arm, open-label examination focused on studying hearts transplanted after non-ischemic heart preservation from extended donors, especially Donation after Circulatory Death (DCD) hearts. XVIVO’s heart preservation technology’s distinctive feature is its non-ischemic hypothermic perfusion system, which uses cold, oxygen-saturated perfusion to maintain donor hearts during transportation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967

What regions are contributing significantly to the growth of the heart transplant market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Arrhythmia Monitoring Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Marker Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Heart Transplant Market, and What Are the Key Drivers?

The market size for heart transplants has seen a swift expansion in the past few years. The growth is predicted to propel from $11.49 billion in 2024 to $12.66 billion in 2025, experiencing a Compound Annual Growth Rate (CAGR) of 10.2%. The surge in this historical period can be credited to progresses in medical technologies, growth in consciousness and learning, developments in organ preservation techniques, and enhancements in healthcare facilities.

The market size for heart transplants is anticipated to witness robust growth in the upcoming years, reaching a value of $18.1 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. The growth during this projection period can be ascribed to factors such as government assistance and funding, globalization of transplant initiatives, expansion of transplant center capacities, and the incorporation of telemedicine and remote monitoring. Key trends projected for this period include technological innovations, artificial heart and support devices, and the use of artificial intelligence (AI) in donor organ selection.

What Are the Primary Drivers Supporting the Growth of the heart transplant Market?

The expansion of the heart transplant market is expected to be driven by the increasing prevalence of cardiovascular diseases. These diseases, which affect the heart and blood vessels, necessitate a heart transplant when no other treatments are effective for people with advanced heart failure. This last-resort treatment enhances the quality of life and extends the lifespan. For example, the British Heart Foundation, a UK-based cardiovascular research charity, reported in September 2024 that about 7.6 million people, including 4 million men and 3.6 million women, are currently suffering from heart and circulatory diseases in the UK. This number is projected to grow by 1 million by 2030, and by another 2 million by 2040, which would add to the present figures. Thus, the increasing prevalence of cardiovascular diseases is expected to stimulate the heart transplant market. Concerning another driver, the heart transplant market is projected to grow due to the mounting awareness surrounding organ donation and transplantation. This awareness is a measure of the knowledge, consciousness, and understanding individuals and communities have about organ donation and transplantation, including its processes, significance, and influence in healthcare. Heightened awareness can positively impact heart transplants by enlarging the donor pool, reducing recipient waiting times, and improving patient results. For instance, the United Network for Organ Sharing, a scientific and educational non-profit organization based in the US, reported a new annual record of 42,887 organ transplants in the US in 2022, which represented a 3.7% increase from 2021. This growth was attributed to established awareness, leading to 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants. Hence, the intensified awareness of organ donation and transplantation is likely to fuel the heart transplant market.

Explore Comprehensive Insights Into The Global Heart Transplant Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Which Companies Are Leading the Charge in Expanding the Heart Transplant Market?

Major companies operating in the heart transplant market are:

• Optum Inc._x000D_

• Novartis Pharmaceuticals UK Ltd._x000D_

• Abbott Laboratories_x000D_

• Medtronic PLC_x000D_

• Stryker Corporation_x000D_

What New Trends Are Reshaping the Heart Transplant Market and Its Opportunities?

Key players in the heart transplant market are prioritizing the creation of groundbreaking strategies such as heart preservation technology to enhance patient results and overall transplant success. This technology notably prolongs the time the heart can be kept outside the body as compared to conventional ice storage, leading to better post-transplant results and fewer complications. For example, in May 2023, Xvivo Perfusion AB, a medical technology firm based in Sweden, received U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application for its heart preservation technology, paving the way for the initiation of the “PRESERVE Clinical Trial.” This is a single-arm, multicenter, open-label, prospective study primarily aimed at assessing hearts transplanted after non-ischemic heart preservation involving extended donors, particularly those involving Donation after Circulatory Death (DCD) hearts. XVIVO’s heart preservation technology is exceptionally unique due to its non-ischemic hypothermic perfusion system, which uses oxygenated cold perfusion to maintain donor hearts during transportation.

Secure Your Global Heart Transplant Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

What Are the Core Categories and Segments in the Heart Transplant Market Driving Demand and Growth?

The heart transplant market covered in this report is segmented –

1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types

2) By Transplant: Autograft, Allograft, Other Transplants

3) By End-User: Hospitals, Cardiac Institutes, Other End-Users

Subsegments:

1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart

2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)

3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)

4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant

What Are the Top Regions Fueling Growth in the Heart Transplant Market?

North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Heart Transplant Market Defined Across Different Regions?

A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.

Browse Through More Similar Reports By The Business Research Company:

Cardiac Arrhythmia Monitoring Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Cardiac Biomarkers Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Marker Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: